"von willebrand disease natural treatment" - Google News
[unable to retrieve full-text content]
Hemab Therapeutics Presents Interim Data from Ongoing Phase 2 Study of HMB-001 as First Ever Prophylactic Treatment in Glanzmann Thrombasthenia and Preclinical Data from HMB-002 in Von Willebrand Disease at the 2025 EAHAD Annual Congress PR Newswire
Comments
Post a Comment